key: cord-0948701-65nfz65j authors: Guillaume, Fond; Marc, Masson; Christophe, Lancon; Raphaelle, Richieri; Eric, Guedj title: The neuroinflammatory pathways of post-SARS-CoV-2 psychiatric disorders date: 2021-08-30 journal: Encephale DOI: 10.1016/j.encep.2021.08.001 sha: f21b9672f97ecd328a5fa17d039a8d5ad4dbb9ac doc_id: 948701 cord_uid: 65nfz65j nan Strict containment public health policies have been carried out to limit the spread of SARS-CoV-2 outbreak, especially during the first wave when many countries have experienced schools and universities closure with important psychological consequences for children and students, and also for parents, including sleep anxiety and mood disorders [1, 2] . Beyond such obvious psychological consequences of lockdown, the tricky issue could be to determine if the SARS-CoV-2 infection is also straightly associated with increased psychiatric disorders by neurotropism. This "neurocovid" hypothesis is consistent with several recent findings in the field of neuropsychoimmunology. First, several psychiatric disorders have been associated at onset and progression with neuroinflammatory processes in neuroimaging PET studies [3] . Second, the two previous coronaviruses (severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)) have shown neuropsychiatric complications [4] . In this line, the association between neurotropic respiratory viruses and brain changes has been documented since influenzae epidemic of 1918 [5] . These complications may be due to direct effects of viral infection, or indirect effects including immuneinflammatory response /cytokine disturbances, hypoxia, or vascular disturbances. In the context of COVID-19, we know that infected individuals (with or without history of psychiatric diagnoses) are at increased risk of intracranial hemorrhage, ischemic stroke, dementia or psychiatric disorder onset (anxiety mood and psychotic disorder) within the 200 days following index SARS-CoV-2 infection [6] . This infection has been further associated with alteration of limbic PET metabolism, similarly in adult and pediatric populations [7, 8] , and linked to initial brain inflammation [9] . In this line, a recent review of 90 studies including neuroimaging and post-mortem analysis identified temporo-frontal areas as the most consistent cross-etiology impairment, with also microglial activation, and viral DNA detection in olfactory and orbitofrontal areas [10] . These regions have the highest concentrations of angiotensin-converting enzyme 2 (ACE2) receptor on cell surface, the receptor binding to the 1 subunit of the S protein, one of the four structural proteins of the SARS-CoV-2 virion [11] . The involvement of these limbic brain structures is well-known in emotion regulation and psychiatric disorders [12] . While individuals with severe psychiatric disorders have increased risk of mortality or ICU admission [13] [14] [15] , we should not exclude that the infection itself may also more directly contribute to the degradation of mental health in infected people. This should be considered in the benefit/risk balance of non-pharmaceutical interventions taken to limit SARS-COV-2 spread, against psychological consequences of these containment measures. Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy Impact of Coronavirus Disease 2019 (COVID-19) Outbreak Quarantine, Isolation, and Lockdown Policies on Mental Health and Suicide Neuroinflammation in psychiatric disorders: PET imaging and promising new targets Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic The emergence of cognitive COVID 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records 18F-FDG brain PET hypometabolism in patients with long COVID Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series From early limbic inflammation to long COVID sequelae Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor The limbic system. An overview of the anatomy and its development Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study Increased in-hospital mortality from COVID-19 in patients with schizophrenia COVID-19 and mental disorders: Toward promotion of preventive care